BioCentury
ARTICLE | Clinical News

Invicorp self-injection formulation of vasoactive intestinal polypeptide and phentolamine: Phase III testing

October 7, 1996 7:00 AM UTC

Senetek PLC (SNTKY), St. Louis, Mo. Product: Invicorp self-injection formulation of vasoactive intestinal polypeptide and phentolamine Indication: Erectile dysfunction Status: SNTKY announced that Ph...